Literature DB >> 9200611

Chaperonin-mediated folding in the eukaryotic cytosol proceeds through rounds of release of native and nonnative forms.

G W Farr1, E C Scharl, R J Schumacher, S Sondek, A L Horwich.   

Abstract

The eukaryotic cytosolic chaperonin, CCT, plays an essential role in mediating ATP-dependent folding of actin and tubulin. There is debate about whether it mediates folding through a single round of association followed by release of native forms, or through cycles of binding and full release in which only a fraction of released molecules reaches native form in any cycle. We examine the fate of newly synthesized substrate proteins bound to CCT in reticulocyte lysate or intact Xenopus oocytes. When a chaperonin "trap," able to bind but not release substrate protein, is introduced, production of the native state is strongly inhibited, associated with transfer to trap. While predominantly nonnative forms of actin, tubulin, and a newly identified substrate, G(alpha)-transducin, are released from CCT, a small fraction reaches native form with each round of release, inaccessible to trap. This overall mechanism resembles that of the bacterial chaperonin, GroEL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200611     DOI: 10.1016/s0092-8674(00)80278-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  47 in total

Review 1.  Chaperone rings in protein folding and degradation.

Authors:  A L Horwich; E U Weber-Ban; D Finley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT.

Authors:  Jaime Martín-Benito; Jasminka Boskovic; Paulino Gómez-Puertas; José L Carrascosa; C Torrey Simons; Sally A Lewis; Francesca Bartolini; Nicholas J Cowan; José M Valpuesta
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  TRiC/CCT cooperates with different upstream chaperones in the folding of distinct protein classes.

Authors:  Katja Siegers; Bettina Bölter; Juliane P Schwarz; Ulrike M K Böttcher; Suranjana Guha; F Ulrich Hartl
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 4.  Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets.

Authors:  Christoph Spiess; Anne S Meyer; Stefanie Reissmann; Judith Frydman
Journal:  Trends Cell Biol       Date:  2004-11       Impact factor: 20.808

5.  Cytosolic chaperonin protects folding intermediates of Gbeta from aggregation by recognizing hydrophobic beta-strands.

Authors:  Susumu Kubota; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 6.  Development of free-energy-based models for chaperonin containing TCP-1 mediated folding of actin.

Authors:  Gabriel M Altschuler; Keith R Willison
Journal:  J R Soc Interface       Date:  2008-12-06       Impact factor: 4.118

Review 7.  Ric-8 regulation of heterotrimeric G proteins.

Authors:  Gregory G Tall
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

8.  Comparative analysis of the protein folding activities of two chaperonin subunits of Thermococcus strain KS-1: the effects of beryllium fluoride.

Authors:  Takao Yoshida; Ryo Iizuka; Keisuke Itami; Takuo Yasunaga; Haruhiko Sakuraba; Toshihisa Ohshima; Masafumi Yohda; Tadashi Maruyama
Journal:  Extremophiles       Date:  2006-10-28       Impact factor: 2.395

9.  Role of the DnaK and HscA homologs of Hsp70 chaperones in protein folding in E.coli.

Authors:  T Hesterkamp; B Bukau
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Up-Regulation of CCT8 Related to Neuronal Apoptosis after Traumatic Brain Injury in Adult Rats.

Authors:  Xiaohong Wu; Haiyan Zhang; Dongjian Chen; Yan Song; Rong Qian; Chen Chen; Xingxing Mao; Xinlei Chen; Weidong Zhang; Bai Shao; Jianhong Shen; Yaohua Yan; Xinmin Wu; Yonghua Liu
Journal:  Neurochem Res       Date:  2015-08-19       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.